Mixed trend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up since Aug 11 · above the Ichimoku cloud · RSI 46 · MACD below its signal
None of the 29 investors followed here reported a position in ANEB in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ANEB trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for ANEB.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.0 | -65.7 | 175.0 | -55.6 | 6.8 | -16.0 | -16.5 | -4.5 | 1.6 | -1.6 | −68.8% | ||
| 2025 | -8.6 | -24.5 | 12.1 | -6.9 | -13.7 | 37.9 | 85.4 | -6.4 | 0.0 | 5.6 | -11.4 | -56.8 | −39.9% |
| 2024 | 6.4 | 5.6 | 5.5 | 1.0 | -29.3 | 33.2 | -12.1 | -20.0 | 0.5 | -2.6 | -23.4 | 16.7 | −30.6% |
| 2023 | 5.2 | 20.8 | -5.8 | 0.7 | -22.6 | 4.0 | -8.1 | 29.2 | 9.5 | -28.0 | 3.6 | 6.1 | −0.2% |
| 2022 | 7.5 | 10.3 | -2.9 | -47.6 | -27.2 | 92.6 | -42.6 | 16.2 | -19.3 | -13.9 | -8.7 | 10.2 | −60.6% |
| 2021 | -16.8 | 6.4 | -7.0 | -3.0 | 1.5 | -9.8 | 2.5 | −25.0% |
No analyst coverage for this instrument.
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. The company's lead product candidate is the selonabant, a small-molecule antagonist of cannabinoid binding receptor type-1(CB1), which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Lakeway, Texas.